79
views
0
recommends
+1 Recommend
0 collections
    2
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Age-related hearing impairment and frailty in Alzheimer's disease: interconnected associations and mechanisms

      editorial

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Among potentially modifiable age-related conditions linked to dementia, Alzheimer's disease (AD), and late-life cognitive disorders, age-related hearing impairment (ARHI) or presbycusis is the most widely diffused sensory disorder and one of the principal causes of chronic disability in older adults (Gates and Mills, 2005). The impairments of peripheral (sensory or strial) and central (predominantly neural) auditory pathways, diagnosed with different procedures, are often variously imbricated in determining ARHI, with mixed clinical findings (Gates and Mills, 2005). A growing body of epidemiological evidence linking ARHI with late-life cognitive disorders (Panza et al., 2015a) suggested the potential for correcting hearing loss so that elders can function better also from a cognitive point of view with appropriate treatment. ARHI is also a substantial marker for frailty in older age, another age-related clinical condition for identifying older persons at elevated risk for numerous adverse health outcomes such as falls, institutionalization, hospitalization, disability, and death (Rodríguez-Mañas, 2013). Frailty is as a multidimensional syndrome characterized by a nonspecific state of vulnerability, reduced multisystem physiological reserve, and decreased resistance to stressors (Rodríguez-Mañas, 2013). Although there is no consensus regarding the operational definition of frailty, in general, two are the most frequently used approaches: the first is the physical or “phenotypic” model of frailty, while the second is based on deficit accumulation, measured with the so called frailty indexes, and defined as an accumulation of health-related deficits and disorders (Rodríguez-Mañas, 2013). However, also psychological, cognitive and social factors are part of this multidimensional syndrome, with great influence on its definition and treatment. Cognition has already been suggested as a possible component of frailty with increased risk of adverse outcomes. Therefore, the prevention of cognitive-related adverse outcomes including delirium (Eeles et al., 2012) and late-life cognitive disorders (Robertson et al., 2013; Panza et al., 2015b) may be possible also through frailty prevention. Peripheral age-related hearing impairment, Alzheimer's disease, and cognition In the USA, ARHI is even more prevalent among older adults than previously reported, with the ARHI prevalence that approximately doubles every decade of life from the second through to the seventh decade (Quaranta et al., 2015). At early stage, ARHI typically affects audibility of the higher frequencies (6000 and 8000 Hz), interfering with regular speech comprehension in both quiet and noise, and spreading to the mid and low frequencies over time. Part of the hearing problems are not related to the peripheral deficit of the auditory system but to the central auditory processing (CAP) dysfunction. Subjects with this condition have considerable difficulty in understanding speech in presence of a background noise or in reverberant rooms, but no problem in a quiet environment. Both peripheral and central auditory dysfunctions are therefore relevant to assess a possible influence of ARHI on late-life cognitive disorders. Over two decades ago, a review article with also original findings summarized the first 25 years of research on possible associations between hearing impairment and cognitive dysfunction reviewing a relevant number of reports (Gennis et al., 1991). The cumulative evidence coming from this first series of studies suggested a strong link between peripheral ARHI and cognitive impairment or decline in demented or institutionalized patients, while there was no association in nondemented older subjects (Gennis et al., 1991). More recently, a case-control report on AD patients from a tertiary center (Gold et al., 1996) and a number of cross-sectional (Gussekloo et al., 2005; Lin, 2011) and longitudinal population-based studies (Lin et al., 2004, 2011, 2013; Valentijn et al., 2005; Wallhagen et al., 2008; Gallacher et al., 2012; Kiely et al., 2012) (Table 1) confirmed the interplay among peripheral auditory dysfunction and AD, dementia, and cognitive disorders in older age, with a single exception in a 2-year follow-up of the Australian Longitudinal Study of Aging (Anstey et al., 2001). However, a weak association between hearing loss and memory decline was found in a re-evaluation of the same sample in a longer follow-up of 8 years (Anstey et al., 2003) (Table 1). Table 1 Principal case-control and longitudinal population-based studies of peripheral auditory dysfunction and central auditory processing dysfunction in age-related hearing impairment in relation to late-life cognitive decline, incident dementia and Alzheimer's disease (AD). References Subjects Assessment of auditory function Assessment of cognition or diagnosis of dementia Covariates Principal findings PERIPHERAL AUDITORY DYSFUNCTION Anstey et al., 2001 The Australian Longitudinal Study of Aging Australia 2087 subjects aged 70–96 years Pure-tone audiometry with portable audiometers Similarities and DSS from WAIS-R, BNT, and NART Age In a 2-year follow-up, decline in hearing was not associated with decline in any cognitive domain Anstey et al., 2003 The Australian Longitudinal Study of Aging Australia 525 subjects, mean age 74.7 years Pure-tone audiometry with portable audiometers Similarities and DSS from WAIS-R, BNT, and NART Age, gender, depressive symptoms, self-rated health, and medical comorbidities In a 8-year follow-up, a weak association between hearing decline and memory decline was found Lin et al., 2004 The Study of Osteoporotic Fractures (SOF) USA 6112 women aged 69 years and older Pure-tone audiometry with hand-held audiometers 3MS and functional status assessed with five activities: walking, climbing stairs, preparing meals, shopping, and doing housework Medical comorbidities, age, education level, smoking, presence of vertebral fracture, benzodiazepine use, BMI, Lubben social network, grip strength, walking speed, and baseline cognitive or functional status Combined hearing and vision impairment was associated with cognitive and functional decline after a 4-year follow-up period Valentijn et al., 2005 The Maastricht Aging Study The Netherlands 418 subjects aged 55 years and older Pure-tone audiometry VVLT, SCWT, CST, VFT, and LDST Age, sex, education level, baseline cognitive performance, change in vision or hearing, and baseline vision or hearing A change in auditory acuity predicted change in memory performance, and auditory acuity at baseline predicted change in the mean score of the first two SCWT cards and the LDST in a 6-year follow-up Wallhagen et al., 2008 The Alameda County Study USA 2002 subjects aged 50–94 years Self-report A self-report measure of cognitive functioning Chronic conditions, age, sex, and education level In a 5-year follow-up, a relationship between baseline hearing impairment and subsequent poorer cognitive function was found in both existing and new cases of cognitive impairment Lin et al., 2011 The Baltimore Longitudinal Study of Aging USA 639 subjects aged 36–90 years Pure-tone audiometry Diagnoses of dementia and AD using DSM-III-R and NINCDS-ADRDA criteria Sex, age, race, education level, diabetes, smoking, hypertension, and hearing aid use During a median follow-up of 11.9 years, baseline hearing loss was independently associated with incident all-cause dementia Gallacher et al., 2012 The Caerphilly cohort United Kingdom 1057 men mean age 56.2 years Pure-tone audiometry. Diagnoses of dementia and AD using DSM-IV and NINCDS-ADRDA criteria. MMSE, CAMCOG, AH4, and CRT Age, social class, anxiety, and premorbid cognitive ability Over a 17-year period, auditory threshold was found to be associated with incident dementia and cognitive decline. An additional effect of change in auditory threshold over 8 years was found for nonvascular dementia Kiely et al., 2012 The Dynamic Analyses to Optimize Aging Project Australia 4221 subjects aged 50–103 years Pure-tone audiometry. MMSE Age, sex, diabetes, stroke, hypertension, visual impairment, smoking status, workplace noise exposure, and high-frequency audiometric noise notches Cognitive impairment and hypertension were independently associated with lower levels and accelerated declines of peripheral hearing, and incidence of cognitive impairment was also associated with poorer hearing function in a 11-year follow-up Lin et al., 2013 The Health ABC Study USA 1984 subjects mean age: 77.4 Years Pure-tone audiometry. 3MS and DSS Age, sex, race/ethnicity, education level, study site, smoking status, hypertension, diabetes mellitus, and stroke history In a 6-year follow-up, hearing loss was independently associated with accelerated cognitive decline and incident cognitive impairment CENTRAL AUDITORY PROCESSING DYSFUNCTION Gennis et al., 1991 USA 112 community-dwelling adults aged 60 years and older Pure-tone audiometry and SPIN WMS and JCST Age and sex In a 5-years follow-up, no evidence that peripheral or central hearing impairment predicted cognitive decline was found Gates et al., 1996 Framingham Heart study USA Population-based, 1662 people aged 63–95 years Pure-tone audiometry and SSI-ICM MMSE and diagnosis of dementia and AD using NINCDS-ADRDA criteria Age and education level In a 6-year follow-up, CAP dysfunction in one ear increased the risk of subsequent dementia or cognitive decline; CAP deficit present in both ears doubled the risk Gates et al., 2002 Framingham Heart study USA Population-based, 740 people aged 63–95 years Pure-tone audiometry and SSI-ICM MMSE and diagnosis of probable AD using NINCDS-ADRDA criteria Age, gender, education level, APOE e4 allele presence, and hearing level In a 8-year follow-up, CAP dysfunction presence was associated with a 10 times higher risk for developing AD Gates et al., 2011 The Adult Changes in Thought Study USA Population-based, 274 people aged 71–96 years Pure-tone audiometry, SSI-ICM, DSI test, and DDT CASI and diagnoses of dementia and AD using DSM-IV and NINCDS-ADRDA criteria Education level In a 3-year follow-up, severe CAP dysfunction strongly predicted the risk of a subsequent diagnosis of AD Idrizbegovic et al., 2013 Sweden Case-control, 70 participants aged 50–80 years with MCI or AD and SMC Pure-tone audiometry, SPIN, and DDT MMSE, MCI diagnosis, and diagnoses of dementia and AD using DSM-IV and NINCDS-ADRDA criteria None In a 1.5-year follow-up, CAP showed a significant decline in the AD group compared with the controls/SMC subjects (left ear) DSS, Digit Symbol Substitution subscale; WAIS-R, Wechsler Adult Intelligence Scale-revised; BNT, Boston Naming Test; NART, National Adult Reading Test; 3MS, modified version of Mini-Mental State Examination; BMI, body mass index; VVLT, Visual Verbal Learning Test; SCWT, Stroop Color Word Test; CST, Concept Shifting Task; VFT, Verbal Fluency Test; LDST, Letter-Digit Substitution Test; DSM-III-R, Diagnostic and Statistical Manual of Mental Disorders, third edition, revised; NINCDS-ADRDA, National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association; MMSE, Mini-Mental State Examination; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition; CAMCOG, Cambridge Cognitive Examination; AH4, Alice Heim test; CRT, 4-choice reaction time task; SPIN, Speech perception in noise; WMS, Wechsler Memory Scale; JCST, Jacobs Cognitive Screening Test; SSI-ICM, Synthetic sentence identification with either an ipsilateral competing message; APOE, apolipoprotein E; DSI, dichotic sentence identification; DDT, dichotic digits test; CASI, Cognitive Abilities Screening Instrument; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition; MCI, mild cognitive impairment; SMC, subjective memory complaints. Central auditory processing dysfunction, mild cognitive impairment, and Alzheimer's disease Age-related decline in CAP appeared not to be an isolated condition, but an entity with a multifactorial nature associated to age- and/or disease-related brain and auditory changes (Gates and Mills, 2005). In fact, CAP dysfunction increases with age (Gates and Mills, 2005), but given the increased incidence of both peripheral ARHI and cognitive impairment in late life, the interpretation of central auditory tests may be difficult. In particular, in the early phase of cognitive decline, the differential impact of the two types of auditory deficits on late-life cognitive disorders may be not easy to determine. Several existing studies mostly focused on the impact of peripheral auditory deficit on late-life cognition, while studies on the link between CAP dysfunction and mild cognitive impairment (MCI) or AD are sparse (Gennis et al., 1991; Kurylo et al., 1993; Gates et al., 1996, 2002, 2008, 2010, 2011; Idrizbegovic et al., 2011, 2013). Several cross-sectional case-control (Kurylo et al., 1993; Idrizbegovic et al., 2011) and two population-based studies (Gates et al., 2008, 2010) suggested a strong involvement of CAP dysfunction in MCI (Idrizbegovic et al., 2011), dementia (Gates et al., 2010), and AD (Kurylo et al., 1993; Gates et al., 2008; Idrizbegovic et al., 2011). In particular, findings from the Adult Changes in Thought (ACT) Study suggested that CAP disorders may be associated with executive dysfunction in older subject with and without memory loss and dementia (Gates et al., 2010). Therefore, executive control function may be a key factor in the speech-based behavioral tasks evaluating CAP dysfunction because lesions of the central auditory pathway are infrequent in early AD (Kurylo et al., 1993). A few longitudinal case-control (Idrizbegovic et al., 2013) and population-based studies (Gates et al., 1996, 2002, 2011) suggested that CAP dysfunction in ARHI may be central in determining an increased risk of cognitive decline and incident dementia or AD (Gates et al., 1996), and AD (Gates et al., 2002, 2011) (Table 1). Therefore, deficit in CAP could be an early marker of MCI or AD, with a “gradient” existing in CAP disorders among subjects with subjective memory complaints, MCI, and early AD (Idrizbegovic et al., 2011). Age-related hearing impairment-dementia link and frailty Some factors may be involved in causal mechanistic pathways linking ARHI and cognition, while other factors may constitute shared pathological processes or etiological pathways underlying both ARHI and cognitive disorders in late life. Cognitive testing may be confounded by ARHI in association with poor verbal communication. However, some studies used also nonverbal cognitive tests or were insensitive to the exclusion of subjects with serious hearing loss from the analyses (Anstey et al., 2003; Lin et al., 2013), so not supporting the hypothesis that miscommunication in hearing loss should impair cognitive testing. Furthermore, in older subjects with subclinical cognitive impairment may occur an overdiagnosis of peripheral ARHI, although audiometric testing appeared to be reliable also in patients with early dementia. Evidence coming from epidemiological (Fratiglioni et al., 2000; Wilson et al., 2007) and neuropathological studies (Bennett et al., 2006) suggested that social isolation and loneliness, caused by communication impairments in older subjects with ARHI, may lead to cognitive decline and AD. Moreover, also the cognitive reserve concept, often conditioned by communication defects, may account for the link between ARHI and cognition. Cognitive/brain reserve appears to be a buffer against the functional impairments caused by accumulating age-related brain changes or AD-related pathology, so acting as a modulator of the interplay between neuropathology and cognitive outcomes. Increased cognitive load to help compensate auditory processing may reduce the neural resources available to other cognitive processes such as working memory and perceptual speed, increasing the deleterious effects of AD pathology and revealing the earlier clinical symptoms of dementia (Boyle et al., 2008). Furthermore, a key link between communication difficulties, social isolation, and cognitive decline is the reduced capacity to participate in mentally stimulating activities. In fact, cognitive reserve acts as a buffer via engaging in cognitively stimulating behaviors within an enriched environment, so enhancing neuroplasticity, Furthermore, while AD-related neuropathology is absent in the peripheral auditory pathways (Sinha et al., 1993), peripheral ARHI may contribute to loss of gray matter volume in primary auditory cortex (Peelle et al., 2011), accelerated rates of decline in regional brain volumes in the right temporal lobe and whole brain volume (Lin et al., 2014), and variation in the integrity of central auditory white matter tracks (Chang et al., 2004). AD-related neurodegeneration may be also involved in peculiar damage of central auditory nuclei required for higher-order auditory processing (Parvizi et al., 2001). However, more serious effects may be caused by damage to higher-order cortical areas involved in language processing (Kurylo et al., 1993), so not excluding a shared neuropathological origin underlying both ARHI and AD/dementia. Among possible confounders, common pathological processes, or shared etiological pathways linking ARHI and cognition, frailty syndrome could have a central role. In fact, ARHI may be also a strong indicator for both the most widely diffused models of frailty. In some operational definitions and frailty indexes, ARHI is one of the suggested components of frailty (Frailty Index-Comprehensive Geriatric Assessment, Groningen Frailty Indicator, and Puts model) (Panza et al., 2015a) and it may predict functional decline or incident falls in older adults (Lin and Ferrucci, 2012), some of the health-related adverse outcomes linked to frailty. Among potentially modifiable risk factors, there is a growing body of evidence about the impact of several operational definitions of frailty on late-life cognitive disorders (Robertson et al., 2013; Panza et al., 2015b). In particular, an international consensus group has recently proposed the clinical label “cognitive frailty” for describing the simultaneous presence of both physical frailty and cognitive impairment in nondemented older individuals (Kelaiditi et al., 2013), representing also a possible precursor of neurodegenerative processes and AD. Epidemiological studies strongly suggested that physical frailty may be associated with incident AD and MCI, nonAD dementias, vascular dementia (VaD), AD-related neuropathology, and cognitive impairment and decline in late life (Robertson et al., 2013; Solfrizzi et al., 2013; Panza et al., 2015b), so also validating cognitive frailty as a new clinical condition. Several factors and diseases associated with physical frailty are also related to cognitive impairment, including nutritional factors, metabolic disorders, inflammatory markers, hormones, diabetes mellitus, congestive heart failure, and stroke (Robertson et al., 2013; Panza et al., 2015b), suggesting an underlying and shared pathogenesis probably linked to vascular determinants. In fact, in 2006, the term “cognitive frailty” was firstly used to indicate a specific state of cognitive vulnerability in MCI and related entities exposed to vascular risk with a consequent elevated progression to dementia (Panza et al., 2006). Physical frailty has been proposed also as a prodromal stage of VaD (Robertson et al., 2013; Solfrizzi et al., 2013). This could be therefore a further common pathway explaining the ARHI-frailty-cognition interplay given that another neurobiological process such as vascular disease or shared vascular factors may cause ARHI, frailty, and dementia. Conclusions and future directions In recent years, there has been growing attention on the possible correlations between sensorial abnormalities and late-life cognitive disorders. Epidemiological evidence is mainly focused on peripheral auditory disorders and cognition, but in longitudinal population-based studies both peripheral and CAP dysfunctions appear to be associated with incident cognitive impairment and AD and accelerated cognitive decline. While some randomized controlled trials (RCTs) showed improvement in cognitive function or global measures of change in hearing-aid users not cognitively impaired (Mulrow et al., 1990) or with dementia (Allen et al., 2003), determining whether treating hearing loss could delay cognitive decline and dementia remains an open issue. In fact, RCTs with more representative cohorts and technology (i.e., digital hearing aids or cochlear implants), longer follow-up periods, and estimating the effects of hearing rehabilitative interventions on cognitive and global functioning have never been performed (Lin, 2012). At present, use of amplification can be an effective tool for minimizing the perceived disability of older adults and reducing the AD caregiver burden by enhancing the communication abilities of the patients (Palmer et al., 1998). However, hearing aids alone could be not enough to properly manage ARHI, and interventions should be broader, incorporating also concerted counseling, environmental accommodations, and rehabilitative hearing training. Cognition and dementia are causally linked to frailty, and ARHI is also a component of frailty included in several operational definitions. Therefore, frailty could have an important impact in the prevention of late-life cognitive disorders, with nutrition and physical exercise as factors potentially affecting frailty status in advanced age (Clegg et al., 2013). Further investigation on the role of vascular risk on the ARHI-frailty-cognition interplay is warranted to better understand causal mechanisms. Overlaps or interactions among the contributing factors could be investigated supplementing speech-based behavioral measures of CAP with nonbehavioral measures based on electrophysiological studies, and structural, spectroscopic, and functional neuroimaging to detect shared neurobiological markers of ARHI and cognitive decline. Conflict of interest statement The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

          Related collections

          Most cited references21

          • Record: found
          • Abstract: found
          • Article: not found

          Age-related hearing impairment-a risk factor and frailty marker for dementia and AD.

          Age-related hearing impairment (ARHI, also known as presbycusis) is potentially a reversible risk factor for dementia and Alzheimer disease (AD). Social isolation, loneliness, poor verbal communication, and cognitive reserve depletion might causally link ARHI with cognitive impairment. ARHI is an important frailty marker, and several factors related to physical frailty could be associated with cognitive impairment. Such factors include inflammatory markers and vascular factors, which might also directly contribute to ARHI. Randomized controlled trials of potential interventions, and larger population-based studies, could facilitate further understanding of the interplay between cognitive impairment, ARHI and frailty in older age. Deficits in both peripheral hearing and central auditory processing (CAP) can contribute to ARHI. Impairments in peripheral hearing and CAP have been linked to accelerated cognitive decline, incident cognitive impairment and AD; moreover, CAP dysfunction is common in mild cognitive impairment (MCI) and AD. Assessment of CAP dysfunction in people with ARHI might, therefore, aid identification of older individuals with increased risk of MCI and AD.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Quality-of-life changes and hearing impairment. A randomized trial.

            To assess whether hearing aids improve the quality of life of elderly persons with hearing loss. Primary care clinics at a Bureau of Veterans Affairs hospital. One hundred and ninety-four elderly veterans who were identified as being hearing impaired from a screening survey involving 771 consecutive clinic patients. Of the original 194, 188 (97%) completed the trial. Subjects were randomly assigned to either receive a hearing aid (n = 95) or join a waiting list (n = 99). MAIN ENDPOINTS: A comprehensive battery of disease-specific and generic quality-of-life measures were administered at baseline, 6 weeks, and 4 months. Persons assigned to the two groups were similar in age, ethnicity, education, marital status, occupation, and comorbid diseases. At baseline, 82% of subjects reported adverse effects on quality of life due to hearing impairment, and 24% were depressed. At follow-up, a significant change in score improvements for social and emotional function (34.0; 95% CI, 27.3 to 40.8; P less than 0.0001), communication function (24.2; CI, 17.2 to 31.2; P less than 0.0001), cognitive function (0.28; CI, 0.08 to 0.48; P = 0.008), and depression (0.80; CI, 0.09 to 1.51; P = 0.03) was seen in subjects who received hearing aids compared with those assigned to the waiting list. Six drop-outs (three per group), no crossovers, and no significant changes in cointerventions were seen. Average, self-reported, daily aid use in the hearing aid group was 8 hours. Hearing loss is associated with important adverse effects on the quality of life of elderly persons, effects which are reversible with hearing aids.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The impact of frailty and delirium on mortality in older inpatients.

              delirium and frailty are common among hospitalised older people but delirium is often missed and frailty considered difficult to measure in clinical practice. to explore the relationship between delirium and frailty in older inpatients and determine their impact on survival. the prospective cohort study of 273 patients aged ≥75 years. patients were screened for delirium at presentation and on alternate days throughout their hospital stay. Frailty status was measured by an index of accumulated deficits (FI), giving a potential score from 0 (no deficits) to 1.0 (all 33 deficits), with 0.25 used as the cut-off between 'fit' and 'frail'. delirium was detected in 102 patients (mean FI: 0.33) and excluded in 171 (mean FI: 0.18) (P < 0.005); 111 patients were frail. Among patients with delirium, the median survival in fit patients was 359 days (95% CI: 118-600) compared with 88 days for those who were frail (95% CI: 5-171; P < 0.05). delirium was associated with higher levels of frailty: the identification of frail patients may help to target those at a greatest risk of delirium. Survival following delirium was poor with the combination of frailty and delirium conferring a particularly bleak prognosis.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Aging Neurosci
                Front Aging Neurosci
                Front. Aging Neurosci.
                Frontiers in Aging Neuroscience
                Frontiers Media S.A.
                1663-4365
                09 June 2015
                2015
                : 7
                : 113
                Affiliations
                [1] 1Neurodegenerative Disease Unit, Department of Basic Medicine, Neuroscience, and Sense Organs, University of Bari Aldo Moro Bari, Italy
                [2] 2Department of Clinical Research in Neurology, University of Bari Aldo Moro, “Pia Fondazione Cardinale G. Panico” Tricase, Italy
                [3] 3Geriatric Unit, Laboratory of Gerontology and Geriatrics, Department of Medical Sciences, IRCCS “Casa Sollievo della Sofferenza” San Giovanni Rotondo, Italy
                [4] 4Geriatric Medicine-Memory Unit and Rare Disease Centre, Interdisciplinary Medicine Department, University of Bari Aldo Moro Bari, Italy
                [5] 5Research and Development Department Chiesi Farmaceutici, Parma, Italy
                [6] 6Otolaryngology Unit, Department of Basic Medical Science, Neuroscience and Sensory Organs, University of Bari Aldo Moro Bari, Italy
                [7] 7Geriatrics Unit, Department of OrthoGeriatrics, Rehabilitation and Stabilitation, Frailty Area, Galliera Hospital NR-HS Genova, Italy
                Author notes

                Edited by: Kaarin J. Anstey, Australian National University College of Medicine, Biology and Environment, Australia

                Reviewed by: Kim Matthew Kiely, The Australian National University, Australia

                *Correspondence: Francesco Panza, geriat.dot@ 123456geriatria.uniba.it

                †These authors have contributed equally to this work.

                Article
                10.3389/fnagi.2015.00113
                4460423
                26106327
                d273ca27-6fe1-4aea-9bf0-ee3dd65c6860
                Copyright © 2015 Panza, Solfrizzi, Seripa, Imbimbo, Capozzo, Quaranta, Pilotto and Logroscino.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 06 March 2015
                : 29 May 2015
                Page count
                Figures: 0, Tables: 1, Equations: 0, References: 46, Pages: 7, Words: 4966
                Categories
                Neuroscience
                Opinion

                Neurosciences
                alzheimer's disease,dementia,mild cognitive impairment,age-related hearing impairment,peripheral auditory dysfunction,central auditory processing deficit,frailty syndrome

                Comments

                Comment on this article

                scite_
                0
                0
                0
                0
                Smart Citations
                0
                0
                0
                0
                Citing PublicationsSupportingMentioningContrasting
                View Citations

                See how this article has been cited at scite.ai

                scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

                Similar content17

                Cited by36

                Most referenced authors565